For in-vitro laboratory research only not for human or veterinary use, diagnosis, or treatment
A patient on semaglutide 2.4 mg who stops engaging with their prescribing platform but continues refilling medication through a pharmacy has no clinical oversight
It is unknown whether SAXENDA causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of liraglutide-induced rodent thyroid C-cell tumors has not been determined (5.1)
Increased cellular energy Higher NAD+ levels translate directly to improved cellular energy production
Stay informed, advocate for yourself, and dont be afraid to ask for help or discounts
Newer options like retatrutide show even more promise in clinical trials